НовостиBenzingaTD Cowen Maintains Buy on Caris Life Sciences, Raises Price Target to $36 TD Cowen Maintains Buy on Caris Life Sciences, Raises Price Target to $36 Benzinga 2026.10.13 15:59 (GMT+0) Открыть на Benzinga Другие новости